San Diego-based Cytori Therapeutics, a company that develops cell-based therapies, has appointed Jeremy Hayden as general counsel and vice president of business development.
“Jeremy possesses a deep and broad knowledge of the life sciences, including both the pharmaceuticals and medical device sectors,” said Marc Hedrick, president and chief executive officer of Cytori, in a statement. “This knowledge, combined with his extensive industry deal experience and his experience with FDA and other regulatory bodies will be a valuable resource.”
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
